webinar
Klebsiella pneumoniae Vaccine Development: Discovery to Clinic
Oct. 15, 2026 10:00 AM EDT I 3:00 PM BST
Register

Glycan Hapten Conjugation Services

Prepare structurally defined glycan–protein conjugates for carbohydrate antibody generation, glycan arrays, lectin studies, coating antigens, and glycan-specific immunoassay development. BOC Sciences combines glycan structure review, reducing-end or site-selective linker planning, carrier pairing, conjugation chemistry, purification, and fit-for-purpose characterization in one project workflow.

Why Glycan Hapten Projects Need Specialized Planning

The Carbohydrate Epitope Is Small and Orientation-Sensitive: A glycan can be chemically correct but biologically underexposed if it is attached too close to the carrier or through the wrong terminus. Linker geometry and attachment orientation are central design variables.

Reducing-End and Site Selectivity Matter: Reducing-end coupling, anomeric control, or site-specific functionalization may be needed to preserve a terminal sugar, branching point, or receptor-binding motif.

Immunogen and Assay Presentation Can Differ: A glycan–KLH immunogen and a glycan–BSA or glycan–OVA coating antigen may need different densities, spacers, or carrier contexts to support a clean screening workflow.

Glycan Density Changes Recognition: Too little glycan may produce weak signal, while excessive loading can alter carrier conformation or create non-physiological multivalency. Cleanup and loading assessment should be built into the project plan.

Custom Glycan Hapten Conjugation Modules

Choose the modules that match your carbohydrate program—from glycan structure review and linker planning to a complete glycan immunogen and coating-antigen package.

01

Glycan Structure and Epitope Review

Review monosaccharide composition, sequence, branching, anomeric configuration, reducing end, and the glycan motif that must remain accessible after conjugation.

  • N-glycan, O-glycan, glycan fragment, or synthetic oligosaccharide targets
  • Sialylated, fucosylated, galactosylated, mannosylated, sulfated, or phosphorylated glycans
  • Glycan sequences supplied as structures, names, literature references, or analytical data
02

Reducing-End and Linker Engineering

Select a reducing-end, anomeric, or side-chain strategy and introduce the spacer needed to display the glycan away from the carrier surface.

  • Reductive amination or other reducing-end approaches
  • Short, flexible, PEG-like, or extended spacers
  • Amine, thiol, azide, alkyne, maleimide, or other conjugation handles
03

Carrier Pairing for Glycan Immunogens and Assays

Plan glycan–KLH, glycan–BSA, glycan–OVA, or other carrier formats around immunization, glycan-array coating, lectin assays, or competitive immunoassays.

  • Glycan immunogen preparation
  • Glycan coating-antigen and assay-reagent selection
  • Matched or differentiated carrier strategy
04

Glycan–Protein Coupling Development

Match the reaction to the glycan handle, carrier reactivity, buffer tolerance, and desired glycan density, then define conditions suitable for repeat batches.

  • Reductive amination, amine/carboxyl, maleimide–thiol, or click-enabled routes
  • Buffer, pH, and carbohydrate stability review
  • Glycan-to-protein ratio and density optimization
05

Purification and Glycan Conjugate Formatting

Remove free glycan, activating reagents, and low-molecular-weight byproducts while maintaining protein recovery and glycan-conjugate solubility.

  • Desalting, dialysis, gel filtration, or other cleanup
  • Buffer exchange for immunization, array, or assay use
  • Recovery, solubility, and storage observations
06

Glycan Density and QC Evidence

Assemble evidence for glycan incorporation, carrier integrity, approximate substitution, free-glycan removal, and suitability for downstream recognition studies.

  • Glycan-loading or substitution estimate
  • Protein recovery and integrity review
  • Immunogen, coating-antigen, or glycan-array build comparison

Glycan Conjugate Architecture: Decisions That Shape Recognition

A productive glycan conjugate is an engineered carbohydrate presentation system, not simply a reaction product. Glycan topology, attachment site, spacer, carrier, density, cleanup, and downstream assay should be planned as one connected design.

Design variables that influence glycan conjugate performance
Design areaCommon optionsQuestion to resolvePractical effect
Glycan identityMonosaccharide, oligosaccharide, branched glycan, glycan fragment, N-glycan, O-glycan, or synthetic motifWhich sugar sequence, branch, or terminal residue must remain recognizable?Defines the carbohydrate epitope presented to antibodies, lectins, or receptors.
Conjugation siteReducing end, anomeric position, terminal residue, side-chain handle, or introduced orthogonal groupCan the glycan be modified without changing the intended epitope?Controls orientation, epitope exposure, and recognition selectivity.
Spacer designMinimal linker, short hydrophilic spacer, PEG-like spacer, or heterobifunctional linkerDoes the glycan need additional distance from the protein surface?Influences accessibility, flexibility, solubility, and nonspecific binding.
Carrier pairingKLH, BSA, OVA, or another project-suitable carrierIs the conjugate for immunization, glycan-array coating, lectin assays, or screening?Connects the glycan presentation to its intended biological workflow.
Glycan densityLow, moderate, or higher carbohydrate substitutionWhat density provides useful signal without overmodifying the carrier?Affects multivalency, avidity, solubility, aggregation, and assay behavior.
Cleanup and formatDesalting, dialysis, gel filtration, buffer exchange, or array/assay-ready formulationWhat must be removed and how will the glycan conjugate be used next?Influences background, storage, reproducibility, and practical usability.

A Practical Development Partner for Glycan Immunoreagents

The project is scoped around molecular requirements, fit-for-purpose evidence, and the intended research use:

Glycan-aware design — Plan around sequence, branching, reducing end, anomeric configuration, and terminal sugar presentation.

Carrier and density flexibility — Compare carrier proteins and glycan substitution levels for immunization, coating, or array use.

Support for complex carbohydrates — Evaluate sialylated, fucosylated, branched, sulfated, phosphorylated, or modified glycans.

Presentation-focused QC — Review glycan incorporation, density, carrier integrity, free-glycan reduction, and handling.

Repeatable glycan builds — Document conjugation conditions that can guide comparative glycan constructs and follow-up batches.

Research-use focus — Align the glycan conjugate format and data package with the next glycobiology experiment.

Conceptual carrier protein displaying glycan haptens on flexible spacers

Illustrative glycan–carrier presentation; glycan density and recognition require experimental assessment.

Applications of Glycan Hapten Conjugates

These research contexts guide material design and require verification in the intended assay or formulation:

Carbohydrate Antibody Generation

  • Glycan–KLH and related immunogens for antibodies against defined sugar sequences, glycan fragments, or disease-associated carbohydrate motifs.

Glycan-Specific Immunoassays

  • Glycan–BSA, glycan–OVA, or other coating antigens for ELISA, competitive formats, and carbohydrate detection studies.

Glycan Array and Lectin Studies

  • Conjugated glycans for immobilization, lectin profiling, glycan–protein recognition, and multivalent binding research.

Sialylated and Fucosylated Glycan Research

  • Custom presentation of sialic-acid-containing, fucosylated, galactosylated, or mannosylated motifs for immunology and glycobiology studies.

Modified and Branched Glycans

  • Conjugates involving branched structures, sulfated or phosphorylated glycans, glycomimetics, or defined glycan fragments.

Glycan Controls and Reference Reagents

  • Research-use glycan conjugates for method development, specificity testing, batch comparison, and internal assay controls.

Six-Stage Glycan Conjugate Development Path

A staged workflow links target definition, preparation, verification, and research-use delivery:

Define the Glycan Recognition Goal

1Define the Glycan Recognition Goal

Confirm the glycan sequence or motif, the binding partner, and whether the material is intended for immunization, array coating, lectin analysis, or an immunoassay.

Confirm project-specific criteria and document the results at this stage.

Select the Attachment Logic

2Select the Attachment Logic

Decide whether reducing-end, anomeric, terminal-residue, or site-specific functionalization best preserves the carbohydrate epitope.

Confirm project-specific criteria and document the results at this stage.

Pair Carrier with Glycan Use Case

3Pair Carrier with Glycan Use Case

Select KLH, BSA, OVA, or another carrier and define the glycan density and conjugate format needed for the next experiment.

Confirm project-specific criteria and document the results at this stage.

Perform Coupling and Purification

4Perform Coupling and Purification

Run the selected glycan–protein reaction, remove free carbohydrate and reagents, and prepare the conjugate in a suitable buffer.

Confirm project-specific criteria and document the results at this stage.

Review Density and Recognition Readiness

5Review Density and Recognition Readiness

Assess glycan incorporation, carrier integrity, approximate substitution, cleanup, solubility, and suitability for downstream recognition studies.

Confirm project-specific criteria and document the results at this stage.

Deliver and Refine the Glycan Build

6Deliver and Refine the Glycan Build

Supply the conjugate with an analytical summary and use the initial build to guide density, linker, or carrier refinements when needed.

Confirm project-specific criteria and document the results at this stage.

Characterization of Glycan–Protein Conjugates

A useful glycan conjugate data package should show that the carbohydrate was incorporated, the carrier remains usable, free glycan has been reduced, and the material is suitable for the next recognition or immunization step.

Methods and acceptance criteria should be agreed during planning because suitability depends on the hapten, carrier, linker, sample amount, and final use.

Typical analytical categories for hapten conjugate projects
CategoryPossible methodsDecision supported
Glycan identity and intermediate checkHPLC/UPLC, LC-MS, HRMS, NMR, glycan profiling, or structure-appropriate analysisConfirms that the glycan or linker-modified carbohydrate is suitable before protein coupling.
Protein recovery and integrityUV absorbance, protein assay, SDS-PAGE, native gel review, or visual solubility assessmentChecks whether the carrier remains recoverable and usable.
Glycan density estimateUV comparison, carbohydrate assay, mass-based comparison, MALDI-TOF where feasible, or project-specific quantitationCompares conjugation conditions and informs glycan-density optimization.
Free-glycan reductionDesalting, dialysis, SEC-style cleanup review, carbohydrate assay, or supernatant analysisShows whether unbound carbohydrate and low-molecular-weight reagents have been reduced.
Handling and storageBuffer-exchange assessment, redissolution check, turbidity observation, and storage reviewIdentifies precipitation, aggregation, or format-specific handling issues before screening.
Matched glycan-build comparisonSide-by-side review of glycan immunogen, coating-antigen, and array-ready constructsConfirms that each glycan reagent is differentiated for its intended recognition workflow.

Discuss Your Glycan Hapten Conjugation Project

Share the glycan structure, sequence, conjugation site, intended assay, or literature reference for an initial project review.

Tell us the glycan sequence or structure, desired carrier, intended use, and whether you need an immunogen, coating antigen, glycan-array reagent, or lectin-binding probe.

Request a consultation or quote. Related services: Glycoconjugate Synthesis Service, Glycan Synthesis Services, Neoglycoprotein Synthesis Service, Glycan Modification and Functionalization Services.

References

  1. Study on the carbohydrate specificity of antibodies formed in rabbits to synthetic glycoproteins with the carbohydrate structure of asialo-glycophorin A PMID 3938524.
  2. Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM197 as carrier protein PMID 32535667.
  3. Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines PMID 30510007.
* Only for research. Not suitable for any diagnostic or therapeutic use.
Send Inquiry
Verification code